Epithelial-mesenchymal transition in liver fibrosis (Review)

Biomedical Reports

Volumn 4, Issue 3, 2016, Pages 269-274

  Zhao, Ya Lei ^a   Zhu, Rong Tao ^a   Sun, Yu Ling ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Fibrogenesis; Hepatic stellate cells; Liver fibrosis; Myofibroblasts; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; DESMIN; FIBRONECTIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOGENIC PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; HUMAN; INFLAMMATION; LIVER FIBROSIS; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; REVIEW; STELLATE CELL; TISSUE INJURY; TISSUE REGENERATION; WOUND HEALING;

EID: 84978900294     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2016.578     Document Type: Review

References (70)

1. Bi WR, Jin CX, Xu GT and Yang CQ: Effect of alendronate sodium on the expression of mesenchymal-epithelial transition markers in mice with liver fibrosis. Exp Ther Med 5: 247-252, 2013.
2. Deng YH, Pu CL, Li YC, Zhu J, Xiang C, Zhang MM and Guo CB: Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia. Dig Dis Sci 56: 731-740, 2011.
3. Yoshida K and Matsuzaki K: Differential regulation of TGF-β/Smad signaling in hepatic stellate cells between acute and chronic liver injuries. Front Physiol 3: 53, 2012.
4. Moreno-Alvarez P, Sosa-Garrocho M, Briones-Orta MA, González-Espinosa C, Medina-Tamayo J, Molina-Jijón E, Pedraza-Chaverri J and Macías-Silva M: Angiotensin II increases mRNA levels of all TGF-beta isoforms in quiescent and activated rat hepatic stellate cells. Cell Biol Int 34: 969-978, 2010.
5. Lee YS and Jeong WI: Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol 27 (Suppl 2): S75-S79, 2012.
6. Rippe RA and Brenner DA: From quiescence to activation: Gene regulation in hepatic stellate cells. Gastroenterology 127: 1260-1262, 2004.
7. Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW and Mann DA: Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: Implications for wound healing and fibrogenesis. Cell Death Differ 14: 275-285, 2007.
8. Tsukamoto H, She H, Hazra S, Cheng J and Miyahara T: Antiadipogenic regulation underlies hepatic stellate cell transdifferentiation. J Gastroenterol Hepatol 21 (Suppl 3): S102-S105, 2006.
9. Elpek GÖ: Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 20: 7260-7276, 2014.
10. Fausther M, Lavoie EG and Dranoff JA: Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep 1: 225-230, 2013.
11. Bosselut N, Housset C, Marcelo P, Rey C, Burmester T, Vinh J, Vaubourdolle M, Cadoret A and Baudin B: Distinct proteomic features of two fibrogenic liver cell populations: Hepatic stellate cells and portal myofibroblasts. Proteomics 10: 1017-1028, 2010.
12. Dranoff JA and Wells RG: Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology 51: 1438-1444, 2010.
13. Uchio K, Tuchweber B, Manabe N, Gabbiani G, Rosenbaum J and Desmoulière A: Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab Invest 82: 619-628, 2002.
14. Iwaisako K, Brenner DA and Kisseleva T: What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27 (Suppl 2): S65-S68, 2012.
15. Tuchweber B, Desmoulière A, Bochaton-Pia llat M L, Rubbia-Brandt L and Gabbiani G: Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 74: 265-278, 1996.
16. Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, Poupon R and Housset C: The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83: 163-173, 2003.
17. Quan TE, Cowper S, Wu SP, Bockenstedt LK and Bucala R: Circulating fibrocytes: Collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36: 598-606, 2004.
18. Strieter RM, Keeley EC, Burdick MD and Mehrad B: The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans Am Clin Climatol Assoc 120: 49-59, 2009.
19. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF and Brenner DA: Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J-Hepatol 45: 429-438, 2006.
20. Kisseleva T and Brenner DA: The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J Hepatol 56: 965-972, 2012.
21. Forbes SJ and Parola M: Liver fibrogenic cells. Best Pract Res Clin Gastroenterol 25: 207-217, 2011.
22. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H and Kalluri R: Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347, 2007.
23. Milani S, Herbst H, Schuppan D, Stein H and Surrenti C: Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 139: 1221-1229, 1991.
24. Pinzani M, Milani S, Herbst H, DeFranco R, Grappone C, Gentilini A, Caligiuri A, Pellegrini G, Ngo DV, Romanelli RG and Gentilini P: Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 148: 785-800, 1996.
25. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, Witek RP, Alpini G, Venter J and Vandongen HM: Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 118: 3331-3342, 2008.
26. Xia JL, Dai C, Michalopoulos GK and Liu Y: Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168: 1500-1512, 2006.
27. Hay ED: An overview of epithelio mesenchymal transformation. Acta Anat (Basel) 154: 8-20, 1995.
28. Zeisberg M and Neilson EG: Biomarkers for epithelialmesenchymal transitions. J Clin Invest 119: 1429-1437, 2009.
29. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE and Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393-405, 1995.
30. Okada H, Danoff TM, Kalluri R and Neilson EG: Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273: F563-F574, 1997.
31. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F and Kalluri R: BMP-7 counteracts TGF-beta1-induced Epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.
32. Lee HY, Jeon HS, Song EK, Han MK, Park SI, Lee SI, Yun HJ, Kim JR, Kim JS, Lee YC, et al: CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: Evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis Rheum 54: 1747-1758, 2006.
33. Iwano M, Plieth D, Danoff TM, Xue C, Okada H and Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
34. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, GustafssonE, Chandraker A, Yuan X, Pu WT, Roberts AB, et al: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13: 952-961, 2007.
35. Potenta S, Zeisberg E and Kalluri R: The role of endo thelial-to-mesenchymal transition in cancer progression. Br J Cancer 99: 1375-1379, 2008.
36. Li Y, Wang J and Asahina K: Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial mesenchymal transition in liver injury. Proc Natl Acad Sci USA 110: 2324-2329, 2013.
37. Pagan R, Martín I, Llobera M andVilaró S: Epithelialmesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide. Hepatology 25: 598-606, 1997.
38. Valdés F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernández M, Benito M, Nieto MA and Fabregat I: The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor beta in fetal rat hepatocytes. Mol Cancer Res 1: 68-78, 2002.
39. Sicklick JK, Choi SS, Bustamante M, McCall SJ, Pérez EH, Huang J, Li YX, Rojkind M and Diehl AM: Evidence for epithelialmesen-chymal transitions in adult liver cells. Am J Physiol Gastrointest Liver Physiol 291: G575-G583, 2006.
40. Xue ZF, Wu XM and Liu M: Hepatic regeneration and the epithelial to mesenchymal transition. World J Gastroenterol 19: 1380-1386, 2013.
41. Yang J and Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107, 2002.
42. Eghbali-Fatourechi G, Sieck GC, Prakash YS, Maercklein P, Gores GJ and Fitzpatrick LA: Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis. Endocrinology 137: 1894-1903, 1996.
43. Hay ED and Zuk A: Transformations between epithelium and mesenchyme: Normal, pathological and experimentally induced. Am J Kidney Dis 26: 678-690, 1995.
44. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
45. Witzgall R, Brown D, Schwarz C and Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994.
46. Klass BR, Grobbelaar AO and Rolfe KJ: Transforming growth factor beta1 signalling, wound healing and repair: A multifunc-tional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J85: 9-14, 2009.
47. Martin M, Lefaix J and Delanian S: TGF-beta1 and radiation fibrosis: A master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47: 277-290, 2000.
48. Del Castillo G, Murillo M M, Alvarez-Barrientos A, Bertran E, Fernández M, Sánchez A and Fabregat I: Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands. Exp Cell Res 312: 2860-2871, 2006.
49. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL and Arteaga CL: Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275: 36803-36810, 2000.
50. Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314: 143-152, 2008.
51. Bhowmick NA, Zent R, Ghiassi M, McDonnell M and Moses HL: Integrin beta 1 signaling is necessary for transforming growth Factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem 276: 46707-46713, 2001.
52. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME and Moses HL: Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6: 603-610, 2004.
53. Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu C, Xiao X, Wu K, Nie Y, Zhang H and Fan D: KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. J Cancer Res Clin Oncol 139: 1033-1042, 2013.
54. Porsch H, Bernert B, Mehić M, Theocharis AD, Heldin CH and Heldin P: Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene 32: 4355-4365, 2013.
55. Ding X, Park SI, McCauley LK and Wang CY: Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. J Biol Chem 288: 10241-10253, 2013.
56. Kim KH, Lee WR, Kang YN, Chang YC and Park KW: Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition. Hum Gene Ther 25: 721-729, 2014.
57. Leask A and Abraham DJ: TGF-beta signaling and the fibrotic response. FASEB J18: 816-827, 2004.
58. Zavadil J, Cermak L, Soto-Nieves N and Böttinger EP: Integration of TGF-beta/Smad and Jagged1/Notch signalling in Epithelial-to-mesenchymal transition. EMBO J 23: 1155-1165, 2004.
59. Park JH, Yoon J, Lee KY and Park B: Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways. Biochimie 113: 26-34, 2015.
60. Lee WR, Kim KH, An HJ, Kim JY, Lee SJ, Han SM, Pak SC and Park KK: Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial mesenchymal transition. Biochem Biophys Res Commun 450: 195-201, 2014.
61. Wang S, Lee Y, Kim J, Hyun J, Lee K, Kim Y and Jung Y: Potential role of Hedgehog pathway in liver response to radiation. PLoS One 8: e74141, 2013.
62. Ingham PW and McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 15: 3059-3087, 2001.
63. van den Brink GR: Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev 87: 1343-1375, 2007.
64. Varjosalo M and Taipale J: Hedgehog: Functions and mechanisms. Genes Dev 22: 2454-2472, 2008.
65. Kahila Bar-Gal G, Kim MJ, Klein A, Shin DH, Oh CS, Kim JW, Kim TH, Kim SB, Grant PR, Pappo O, et al: Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology 56: 1671-1680, 2012.
66. Choi SS, Omenetti A, Witek RP, Moylan CA, Syn WK, Jung Y, Yang L, Sudan DL, Sicklick JK, Michelotti GA, et al: Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 297: G1093-G1106, 2009.
67. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E and Koteish A: Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282: 22089-22101, 2007.
68. Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, Penz-Osterreicher M and Brenner DA: Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51: 1027-1036, 2010.
69. Lee SJ, Kim KH and Park KK: Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition. World J Hepatol 6: 207-216, 2014.
70. Scholten D, Osterreicher CH, Scholten A, Iwaisako K, Gu G, Brenner DA and Kisseleva T: Genetic labeling does not detect Epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139: 987-998, 2010.